BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37410504)

  • 1. T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation.
    Torabi A; Naresh KN
    Blood; 2023 Jul; 142(1):119. PubMed ID: 37410504
    [No Abstract]   [Full Text] [Related]  

  • 2. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
    Sun S; Fang W
    Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.
    Fang H; Beird HC; Wang SA; Ibrahim AF; Tang Z; Tang G; You MJ; Hu S; Xu J; Li S; Yin CC; El Hussein S; Le N; Futreal PA; Bueso-Ramos C; Thakral B; Kadia TM; Thornton R; Little L; Gumbs C; Song X; Medeiros LJ; Wang W
    Leukemia; 2023 Sep; 37(9):1919-1921. PubMed ID: 37443196
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of karyotyping,
    Sun Y; Tang G; Hu Z; Thakral B; Miranda RN; Medeiros LJ; Wang SA
    J Clin Pathol; 2018 Apr; 71(4):309-315. PubMed ID: 28821581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental but rapidly progressing T-cell prolymphocytic leukemia with t(X;14)(q28;q11) involving parotid lymphoepithelial cysts: A diagnostic pitfall.
    Ghosh A; Chen L; Wahed A; Wang W; Saluja K; Nguyen AND; Hu S; Hu Z
    Int J Lab Hematol; 2022 Feb; 44(1):e17-e20. PubMed ID: 34275205
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of BCR/ABL rearrangement in acute and chronic T cell leukemias.
    Simões BP; Scaffo MH; Falcão RP
    Leukemia; 1997 Sep; 11(9):1595-6. PubMed ID: 9305620
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytoplasmic Blebs in T-Cell Prolymphocytic Leukemia.
    Abbas HA; Han X
    N Engl J Med; 2019 Jun; 380(24):2360. PubMed ID: 31189039
    [No Abstract]   [Full Text] [Related]  

  • 9. T-cell prolymphocytic leukemia presenting as ascites.
    Hermans SJF; Sandberg Y
    Blood; 2019 Jul; 134(4):411. PubMed ID: 31345928
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
    Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
    Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia.
    Gallipoli P; Clark A; Leach M
    Am J Hematol; 2009 Nov; 84(11):750-3. PubMed ID: 19714590
    [No Abstract]   [Full Text] [Related]  

  • 13. Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma.
    Andersen MA; Valentin R; Dissing Sjö L; Borgwardt L; Schmiegelow K; Andersen MK; Marvig RL; Yde CW; Niemann CU
    Acta Oncol; 2020 Dec; 59(12):1547-1551. PubMed ID: 32970500
    [No Abstract]   [Full Text] [Related]  

  • 14. T-cell prolymphocytic leukemia with a novel translocation (6;11)(q21;q23).
    Wong KF; Chan JK; Sin VC
    Cancer Genet Cytogenet; 1999 Jun; 111(2):149-51. PubMed ID: 10347553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function.
    Braun T; Klepzig H; Herling M
    Oncotarget; 2023 May; 14():395-397. PubMed ID: 37141408
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactive T-cell prolymphocytic leukemia with negative surface CD3: Cytogenetic pitfalls.
    Flores-Morán MS; Rodríguez-Sevilla JJ; Arenillas L; Calvo X; Puiggros A; Espinet B; Costan B; Rodríguez-Rivera M; Salido M; Ferrer Del Álamo A
    Int J Lab Hematol; 2023 Jun; 45(3):e55-e59. PubMed ID: 36513944
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia.
    Smith VM; Lomas O; Constantine D; Palmer L; Schuh AH; Bruce D; Gonchar O; Macip S; Jayne S; Dyer MJS; Eyre TA
    Blood Adv; 2020 Feb; 4(3):525-529. PubMed ID: 32040552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization.
    Feldman AL; Law M; Grogg KL; Thorland EC; Fink S; Kurtin PJ; Macon WR; Remstein ED; Dogan A
    Am J Clin Pathol; 2008 Aug; 130(2):178-85. PubMed ID: 18628085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell prolymphocytic leukemia: Review of an entity and its differential diagnostic considerations.
    Frater JL
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():90-98. PubMed ID: 32543075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.